SIETES :: 92751 citas

Resultados de la búsqueda por HEROÍNA REFINAR BÚSQUEDA

1.

Haight BR, Learned SM, Lafont CM, Fudala PJ, Zhao Y, Garofalo AS, Greenwald MK, Nadipelli VR, Linq W, Heidbreder C, RB-US-13-0001 Study Investigators. Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2019;393:23 de febrero. [Ref.ID 103111]

2.

Hedegaard H, Bastian BA, Trinidad JP, Spencer M, Warner M. Drugs most frequently involved in drug overdose deaths: United States, 2011–2016. National Vital Statistics Reports 2018;67:12 de diciembre. [Ref.ID 102871]

3.

Strang L, Taylor J. Heroin-assisted treatment and supervised drug consumption sites: experience from four countries. Rand Corporation, Santa Monica, California 2018:5 de diciembre. [Ref.ID 102861]

4.

Hedegaard H, Miniño AM, Warner M. Drug overdose deaths in the United States, 1999–2017.. NCHS Data Brief 2018;329:1-8. [Ref.ID 102855]

5.

Lembke A, Papac J, Humphreys K. Our other prescription drug problem. N Engl J Med 2018;378:22 de febrero. [Ref.ID 102557]

6.

Seth P, Scholl L, Rudd RA, Bacon S. Overdose deaths involving opioids, cocaine, and psychostimulants — United States, 2015–2016. Morbidity and Mortality Weekly Report 2018;67:30 de marzo. [Ref.ID 102488]

7.

Socías ME, Wood E. Epidemic of deaths from fentanyl overdose. BMJ 2017;359:j4355. [Ref.ID 102107]

8.

O'Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden M. Deaths involving fentanyl, fentanyl analogs, and U-47700 — 10 states, July–December 2016. Morbidity and Mortality Weekly Report 2017;66:1-5. [Ref.ID 102103]

9.

Buttram ME, Kurtz SP, Dart RC, Margolin ZR. Law enforcement-derived data on gabapentin diversion and misuse, 2002-2015: diversion rates and qualitative research findings. Pharmacoepidemiol Drug Saf 2017;26:1083-7. [Ref.ID 102063]

10.

Manhapra A, Rosenheck R. Opioid substitution treatment is linked to reduced risk of death in opioid use disorder. BMJ 2017;357:j1947. [Ref.ID 101635]

11.

Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, Ferri M, Pastor-Barriuso R. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ 2017;357:j1550. [Ref.ID 101634]

12.

Gaither JR, Leventhal JM, Ryan SA, et al.. National trends in hospitalizations for opioid poisonings among children and adolescents, 1997 to 2012. JAMA Pediatrics 2016:31 de octubre. [Ref.ID 100870]

13.

Middleton J, McGrail S, Stringer K. Drug related deaths in England and Wales. BMJ 2016;355:i5259. [Ref.ID 100851]

14.

15.

Nuijten M, Blanken P, van de Wetering B, Nuijen B, van den Brink W. Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial. Lancet 2016;387:2226-34. [Ref.ID 100335]

16.

McCarthy M. US needs $1.1bn to treat opioid addiction. BMJ 2016;352:i694. [Ref.ID 100047]

17.

Anónimo. Clarification: half-life of heroin. Med Lett Drugs Ther 2016;58:1. [Ref.ID 100015]

18.

Rudd RA, Aleshire N, Zibbell JE, Gladden M. Increases in drug and opioid overdose deaths — United States, 2000–2014. MMWR Morb Mortal Wkly Rep 2015;64:1-5. [Ref.ID 99739]

19.

Anónimo. Prescription painkiller deaths fall for first time In 15 years. DIA Daily 2014:15 de octubre. [Ref.ID 98097]

20.

Anónimo. Intranasal naloxone for treatment of opioid overdose. Med Lett Drugs Ther 2014;56:21-2. [Ref.ID 97422]